scholarly journals A Novel Mouse Model of Advanced Diabetic Kidney Disease

PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e113459 ◽  
Author(s):  
Jean-Francois Thibodeau ◽  
Chet E. Holterman ◽  
Dylan Burger ◽  
Naomi C. Read ◽  
Timothy L. Reudelhuber ◽  
...  
2011 ◽  
Vol 21 (5) ◽  
pp. 285-291 ◽  
Author(s):  
Ariel Troib ◽  
Daniel Landau ◽  
Jack F. Youngren ◽  
Leonid Kachko ◽  
Ralph Rabkin ◽  
...  

2003 ◽  
Vol 284 (6) ◽  
pp. F1138-F1144 ◽  
Author(s):  
Kumar Sharma ◽  
Peter McCue ◽  
Stephen R. Dunn

Diabetic nephropathy is increasing in incidence and is now the number one cause of end-stage renal disease in the industrialized world. To gain insight into the genetic susceptibility and pathophysiology of diabetic nephropathy, an appropriate mouse model of diabetic nephropathy would be critical. A large number of mouse models of diabetes have been identified and their kidney disease characterized to various degrees. Perhaps the best characterized and most intensively investigated model is the db/ db mouse. Because this model appears to exhibit the most consistent and robust increase in albuminuria and mesangial matrix expansion, it has been used as a model of progressive diabetic renal disease. In this review, we present the findings from various studies on the renal pathology of the db/ db mouse model of diabetes in the context of human diabetic nephropathy. Furthermore, we discuss shortfalls of assessing functional renal disease in mouse models of diabetic kidney disease.


Diabetologia ◽  
2011 ◽  
Vol 54 (10) ◽  
pp. 2713-2723 ◽  
Author(s):  
F. Liu ◽  
H. Y. Chen ◽  
X. R. Huang ◽  
A. C. K. Chung ◽  
L. Zhou ◽  
...  

2020 ◽  
Vol 10 (2) ◽  
pp. e17-e17
Author(s):  
Elisabet Van Loon ◽  
Joseph Pierre Aboumsallem ◽  
Evelyne Lerut ◽  
Marija Bogojevic ◽  
Aleksandar Denic ◽  
...  

2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Keita Shibata ◽  
Erika Yasuda ◽  
Tomoka Nishinaga ◽  
Sarara Karasawa ◽  
Tomoaki Yamaguchi ◽  
...  

2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Shankar Munusamy ◽  
Kayla Olstinske ◽  
Christopher Karch ◽  
Ronald Frantz ◽  
Kevin Carnevale

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Lena William-Olsson ◽  
Pernilla Tonelius ◽  
Tajana Tesan Tomic ◽  
Magnus Söderberg ◽  
Anna Björnson Granqvist

Abstract Background and Aims There is a need of disease relevant models for efficient evaluation of new drug targets in the renal field. The obese diabetic BTBRob/ob mouse model have features resembling important aspects of human diabetic kidney disease and is extensively used in pharmacological studies. Since diet composition plays a role in diabetic- and renal disease it is important to have detailed control of nutritional intake in our pre-clinical models, especially since many studies use in-diet drug administration. In this study we compared disease progression in obese diabetic mice on non-defined chow diet (R3) with the defined control diet D12450B (Research Diets). Method BTBRob/ob mice were fed either regular laboratory rodent chow (R3) or the defined control diet D12450B containing 35% sucrose from 6 weeks of age. The animals were studied for 14 to 20 weeks of age and both physical parameters, urine and blood parameters, histology and gene expression was examined. (R3 group n=14, D12450B group n=8). Results Mice on the defined D12450B diet displayed increased calorie- and water intake, but gained less weight compared to R3 group. Blood glucose and HbA1c was higher at all timepoints, and urinary albumin-to-creatinine ratio was highly elevated compared to mice on R3 diet. Mice fed D12450B also displayed lower levels of plasma insulin and increased plasma b-hydroxybutyrate levels. Histopathological evaluation revealed that the defined D12450B diet increased induction both of mesangial injury score and gene expression of tubular injury markers NGAL and Kim-1. Conclusion : In summary, the choice of diet composition will have a huge impact on the disease progression in diabetic leptin-deficient overeating mouse models. These finding underline the importance of describing the diet composition in detail and take precaution on diet selection for preclinical studies.


Sign in / Sign up

Export Citation Format

Share Document